- The company earned $0.20 per share, beating estimates by $0.04 per share.
- Revenue was $2.84 billion, far higher than the consensus estimate of $2.7 billion.
- The average selling price (ASP) rose 5% while volumes rose 6%.
Proper short-interest analysis may help you get the direction right, but it does not give you any help on the extent of a move.
Jim Cramer shares his views on OPEC, luxury brands and tech.
Cramer says Bluebird Bio is too speculative for him but he likes Enterprise Products Partners.